Literature DB >> 10996974

Health care expenditure inertia in the OECD countries: a heterogeneous analysis.

A A Okunade1, C Suraratdecha.   

Abstract

Health care expenditure studies of the Organization for Economic Cooperation and Development (OECD) countries remain important because their findings often suggest cost containment and other policy initiatives. This paper focuses on the compatibility of OECD health data with the "expenditure inertia" (or lagged adjustments) hypothesis, by modeling individual country time-series data of 21 nations for the 1960-1993 period. Maximum likelihood estimates of the Box-Cox transformation regression models reveal that: (a) the hypothesized impact of health "expenditure inertia" is both pervasive and strong, averaging 0.64 across the countries; (b) the real GDP elasticities of health care expenditures vary widely among the countries and average 0.34 in the short run--implying that health care is a necessity; (c) the long run GDP elasticities are less than 1 in 8 countries, unitary elastic in 8 countries and elastic in 5 countries--suggesting that health care is not universally a necessity or a luxury commodity for the OECD countries; (d) physician-inducement effects (dis-inducement in a few countries) are weak, with a mean elasticity estimate of 0.17; and (e) no unique functional form approximation model is globally compatible with the data across the countries. Health care cost containment policy implications of these findings are explored.

Entities:  

Mesh:

Year:  2000        PMID: 10996974     DOI: 10.1023/a:1019020802989

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  28 in total

1.  On stationarity and cointegration of international health expenditure and GDP.

Authors:  U G Gerdtham; M Löthgren
Journal:  J Health Econ       Date:  2000-07       Impact factor: 3.883

2.  Is health care really a luxury?

Authors:  A G Blomqvist; R A Carter
Journal:  J Health Econ       Date:  1997-04       Impact factor: 3.883

3.  Cross national differences in health spending. What do they mean?

Authors:  J P Newhouse
Journal:  J Health Econ       Date:  1987-06       Impact factor: 3.883

4.  Conversion factor instability in international comparisons of health care expenditure.

Authors:  U G Gerdtham; B Jönsson
Journal:  J Health Econ       Date:  1991-07       Impact factor: 3.883

Review 5.  Physician response to fee changes with multiple payers.

Authors:  T G McGuire; M V Pauly
Journal:  J Health Econ       Date:  1991       Impact factor: 3.883

6.  Hospital cost growth down.

Authors:  S Guterman; J Ashby; T Greene
Journal:  Health Aff (Millwood)       Date:  1996       Impact factor: 6.301

7.  Physician earnings in a changing managed care environment.

Authors:  C J Simon; P H Born
Journal:  Health Aff (Millwood)       Date:  1996       Impact factor: 6.301

8.  Health care reform in The Netherlands, Sweden, and the United Kingdom.

Authors:  C Ham; M Brommels
Journal:  Health Aff (Millwood)       Date:  1994       Impact factor: 6.301

9.  The pharmaceutical industry and health reform: lessons from Europe.

Authors:  J Hutton; M Borowitz; I Oleksy; B R Luce
Journal:  Health Aff (Millwood)       Date:  1994       Impact factor: 6.301

10.  Medical-care expenditure: a cross-national survey.

Authors:  J P Newhouse
Journal:  J Hum Resour       Date:  1977
View more
  6 in total

1.  Managed care, deficit financing, and aggregate health care expenditure in the United States: a cointegration analysis.

Authors:  N R Murthy; A A Okunade
Journal:  Health Care Manag Sci       Date:  2000-09

2.  Economic expansion is a major determinant of physician supply and utilization.

Authors:  Richard A Cooper; Thomas E Getzen; Prakash Laud
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

3.  [Do we spend too much on medications? Pharmaceutical expenditures, an absolutely essential item in European countries].

Authors:  J Simó Miñan; R de Pablo González; M J Ramos Maestre; M S Gaztambide Ganuza
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

4.  Determinants of health expenditure growth of the OECD countries: jackknife resampling plan estimates.

Authors:  Albert A Okunade; Mustafa C Karakus; Charles Okeke
Journal:  Health Care Manag Sci       Date:  2004-08

5.  Is health care a luxury or a necessity or both? Evidence from Turkey.

Authors:  Nilgun Cil Yavuz; Veli Yilanci; Zehra Ayca Ozturk
Journal:  Eur J Health Econ       Date:  2011-07-28

6.  Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy.

Authors:  Mujaheed Shaikh; Afschin Gandjour
Journal:  Health Econ       Date:  2018-10-10       Impact factor: 3.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.